Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Australia
(19/week)
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Guatemala
(0/week)
View all
(19/week)
News
United States
(626/week)
Manufacturing
(450/week)
Energy
(343/week)
Technology
(477/week)
Other Manufacturing
(372/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
Antipsychotic
Aug 29, 2019
Depression Drugs Market to Generate US$ 5000 Million Revenue by 2026, Online Pharmacies to Gain Market Share - TMR
Jul 23, 2019
Schizophrenia Drugs Market Growth, Trends, and Forecast 2019-2024
May 28, 2019
Allergan and Gedeon Richter Receive U.S. FDA Approval For Expanded Use of VRAYLAR® (cariprazine) in the Treatment of Bipolar Depression
May 20, 2019
Neurocrine Biosciences Presents New Data from RE-KINECT, the Largest Real-World Screening Study of Possible Tardive Dyskinesia, Demonstrating the Effect of Involuntary Movements on Patient Quality of Life
May 15, 2019
Allergan to Present VRAYLAR® (cariprazine) Data at the American Psychiatric Association (APA) 2019 Annual Meeting Highlighting Continued Commitment to Mental Health
May 06, 2019
Neurocrine Biosciences Honors Mental Health Month and Raises Awareness of Tardive Dyskinesia and its Impact on Patients
Apr 16, 2019
Cariprazine Shows Better Cognitive Improving Features and Uniquely Favorable Weight Gain Effect Compared to Other Antipsychotics
Apr 09, 2019
Alkermes Announces Positive Topline Results From Innovative Study of ARISTADA® and INVEGA SUSTENNA® for the Treatment of Schizophrenia
Apr 01, 2019
Alkermes to Present New ALKS 3831 Data From ENLIGHTEN-2 and Interim Extension Safety Study Results at 2019 Congress of the Schizophrenia International Research Society
Feb 27, 2019
Indivior Announces Launch of PERSERIS(TM) (risperidone) for the Treatment of Schizophrenia in Adults
Feb 05, 2019
Neurocrine Biosciences Reports Fourth Quarter and Year-End 2018 Financial Results
Jan 16, 2019
New INGREZZA® (valbenazine) Analysis Published in the Journal of Affective Disorders Demonstrates Sustained Improvement in Tardive Dyskinesia Symptoms in Patients with Primary Mood Disorders
Jan 06, 2019
Neurocrine Biosciences Provides Preliminary Fourth Quarter and Full-Year 2018 Net Product Sales Results and 2019 Program Milestones
Dec 13, 2018
Janssen Signs Results-Based Contract with Oklahoma Health Care Authority (OHCA) for its Long-Acting Injectable Schizophrenia Medicines
Dec 12, 2018
Neurocrine Biosciences Announces Topline Data from Phase IIb T-Force GOLD Study Demonstrating Valbenazine Did Not Meet Primary Endpoint in Pediatric Patients with Tourette Syndrome
Nov 15, 2018
Tardive Dyskinesia Treatment: Worldwide Market Projections to 2023 - Increasing Use of Antipsychotic Drugs Across the Globe
Nov 05, 2018
Neurocrine Biosciences Reports Third Quarter 2018 Financial Results
Nov 05, 2018
Researchers use genetics to predict response to antipsychotic medications
Nov 01, 2018
Vanda Receives FDA Letter Regarding Corporate Webpage
Oct 23, 2018
Neurocrine Biosciences to Present New Data Analyses on the Long-Term Effects of INGREZZA® (valbenazine) in Tardive Dyskinesia Patients with Mood Disorders at the 2018 Annual Psych Congress
‹‹
Page 2
››
Latest News
May 7, 2024
Genesis Energy, L.P. Upsizes and Prices Public Offering of Senior Notes
May 7, 2024
AST SpaceMobile Welcomes Andrew Johnson as New Chief Legal Officer
May 7, 2024
Sturm, Ruger & Company, Inc. to Report First Quarter Results and File Quarterly Report on Form 10-Q on...
May 7, 2024
ONX Homes Breaks Ground on 200-Single-Family Home Community in Metro Orlando
May 7, 2024
Nine Energy Service Announces First Quarter 2024 Results
May 7, 2024
Rocket Lab Completes Archimedes Engine Build, Begins Engine Test Campaign
May 7, 2024
Rocket Lab Selects Subcontractors to Support SDA Satellite Constellation Development
May 7, 2024
Forum Energy Technologies to Present at the Sidoti Virtual Investor Conference
View all News
Agenda
29
October
United Kingdom
Copthorne Tara Hotel, London, UK
International Dismounted Soldier, 29-30 October 2024, Copthorne Tara Hotel, London, UK
Navigating the Evolving Battlespace: Enhancing the Capabilities of the Dismounted Soldier The modern battlefield...
24
September
United Kingdom
Hilton London Syon Park, London, UK
Defence Transformation Conference, 24-26 September 2024, Hilton London Syon Park, London, UK
Returning for its 8th year, Defence Transformation 2024 will feature an updated format that will address all aspects of...
17
June
France
Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024, 17 - 21 June 2024, Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024 There can be no sustainable world without peace and security. Founded in 1967, the exhibition...
View All Events